Business Description
Hunan Nucien Pharmaceutical Co Ltd
Share Class Description:
SHSE:688189: Class ACompare
Compare
Traded in other countries / regions
688189.China IPO Date
2020-03-26Description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.38 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -9.8 | |||||
| Interest Coverage | 9.14 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.44 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.1 | |||||
| 3-Year EBITDA Growth Rate | -32.5 | |||||
| 3-Year EPS without NRI Growth Rate | -65.2 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.39 | |||||
| 9-Day RSI | 55.08 | |||||
| 14-Day RSI | 56.16 | |||||
| 6-1 Month Momentum % | -21.75 | |||||
| 12-1 Month Momentum % | -42.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | |||||
| Quick Ratio | 4.23 | |||||
| Cash Ratio | 2.12 | |||||
| Days Inventory | 95.56 | |||||
| Days Sales Outstanding | 494.62 | |||||
| Days Payable | 90.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 14.34 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.13 | |||||
| Operating Margin % | 19.53 | |||||
| Net Margin % | -6.9 | |||||
| FCF Margin % | 43.49 | |||||
| ROE % | -2.21 | |||||
| ROA % | -1.71 | |||||
| ROIC % | 10.3 | |||||
| ROC (Joel Greenblatt) % | -2.19 | |||||
| ROCE % | -1.22 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 36.58 | |||||
| PS Ratio | 4.43 | |||||
| PB Ratio | 1.41 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Free-Cash-Flow | 10.1 | |||||
| Price-to-Operating-Cash-Flow | 8.32 | |||||
| EV-to-EBIT | -92.38 | |||||
| EV-to-EBITDA | -92.38 | |||||
| EV-to-Revenue | 3.5 | |||||
| EV-to-FCF | 8.79 | |||||
| Price-to-Graham-Number | 1.65 | |||||
| Price-to-Net-Current-Asset-Value | 2.16 | |||||
| Price-to-Net-Cash | 6.35 | |||||
| Earnings Yield (Greenblatt) % | -1.08 | |||||
| FCF Yield % | 9.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hunan Nucien Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 421.639 | ||
| EPS (TTM) (Â¥) | -0.106 | ||
| Beta | 1.06 | ||
| Volatility % | 39.02 | ||
| 14-Day RSI | 56.16 | ||
| 14-Day ATR (Â¥) | 0.386691 | ||
| 20-Day SMA (Â¥) | 6.168 | ||
| 12-1 Month Momentum % | -42.74 | ||
| 52-Week Range (Â¥) | 5.22 - 11.52 | ||
| Shares Outstanding (Mil) | 274.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hunan Nucien Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Frequently Asked Questions
What is Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)'s stock price today?
The current price of SHSE:688189 is ¥6.73. The 52 week high of SHSE:688189 is ¥11.52 and 52 week low is ¥5.22.
When is next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)?
The next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) is .
Does Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) pay dividends? If so, how much?
Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers